Rhetan TMT Intrinsic Value
Rhetan TMT (RHETAN) median intrinsic value is ₹7.83 from 9 valuation models (range ₹6–₹20), vs current price ₹19.57 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit Rhetan TMT stock price NSE.
RHETAN Valuation Methods Summary — DCF, Graham Number & P/E
Rhetan TMT intrinsic value across 9 models vs current price ₹19.57 — upside/downside and value range per method. Check RHETAN market value to track the company's total market size over time.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹5.87 | ₹4.70 - ₹7.04 | -70.0% | EPS: ₹0.20, Sector P/E: 12x |
| Book Value Method | asset | ₹13.62 | ₹12.26 - ₹14.98 | -30.4% | Book Value/Share: ₹13.62, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹5.87 | ₹5.28 - ₹6.46 | -70.0% | Revenue/Share: ₹4.50, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹13.50 | ₹12.15 - ₹14.85 | -31.0% | EBITDA: ₹18.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹7.83 | ₹6.26 - ₹9.40 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹5.87 | ₹5.28 - ₹6.46 | -70.0% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹5.87 | ₹5.28 - ₹6.46 | -70.0% | Revenue Growth: -19.8%, Adj P/E: 8.0x |
| ROE Based Valuation | profitability | ₹19.50 | ₹17.55 - ₹21.45 | -0.4% | ROE: 11.9%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹7.83 | ₹7.05 - ₹8.61 | -60.0% | EPS: ₹0.20, BVPS: ₹13.62 |
RHETAN Intrinsic Value vs Market Price — All Valuation Models
Rhetan TMT fair value range ₹6–₹20 vs current market price ₹19.57 across 9 valuation models. See Rhetan TMT P/B ratio trends to compare market price against book value per share.
RHETAN Intrinsic Value Analysis — Undervalued or Overvalued?
Rhetan TMT median intrinsic value ₹7.83, current price ₹19.57 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of RHETAN?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Rhetan TMT (RHETAN) is ₹7.83 (median value). With the current market price of ₹19.57, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹5.87 to ₹19.50, indicating ₹5.87 - ₹19.50.
Is RHETAN undervalued or overvalued?
Based on our multi-method analysis, Rhetan TMT (RHETAN) appears to be trading above calculated value by approximately 60.0%.
RHETAN Financial Health — Key Ratios vs Industry Benchmarks
Rhetan TMT financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.59 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 11.9% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 19.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.22x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
RHETAN Cash Flow Quality — Operating & Free Cash Flow
Rhetan TMT operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹5 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹14 Cr | ₹10 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-44 Cr | ₹-45 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-14 Cr | ₹-14 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-7 Cr | ₹-7 Cr | Negative Cash Flow | 3/10 |